Our research centers on deciphering the molecular mechanisms controlling antitumor immunity, and exploiting knowledge to device new gene- and cell-based cancer immunotherapies.
We have two active research directions:
Our JEM paper reporting creatine uptake regulation of CD8 T cell immunity is featured on UCLA News and other media.
Our Cell Stem Cell paper reporting HSC-engineering iNKT cell cancer therapy is featured on UCLA News and other media. [PDF][UCLA
Dr. Lili Yang receives the Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT). [PDF][Link]